Evaluation of Descemet's Membrane Endothelial Keratoplasty (DMEK) In Cases of Pseudophakic Bullous Keratopathy

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

PACTR

Registry ID

PACTR202507598725276

Enrollment

Registered

2025-07-23

Start date

2023-12-17

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eye Diseases

Interventions

Descemet Membrane Endothelial Keratoplasty

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: eyes with pseudophakic bullous keratopathy

Exclusion criteria

Exclusion criteria: gross corneal swelling with corneal stromal scarring, extensive peripheral anterior synechia (PAS), deformed and irregular anterior chamber (AC), poor visibility, vitreous in anterior chamber, gross posterior segment pathology, uncontrolled glaucoma as identified utilizing USG B-scan.

Design outcomes

Primary

Measure	Time frame
Best-Corrected Visual Acuity	—

Secondary

Measure	Time frame
Endothelial cell density, Endothelial cell loss	—

Countries

Egypt

Contacts

Public ContactMahmoud Ismail

Professor of ophthalmology

eyesofcairo@hotmail.com+201223793159

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026